Dyskinesias developed in 31% of the levodopa patients, but only 10% of the Mirapex patients.
BBC: Parkinson's drug breakthrough
The researchers found that the impact of the drugs was less likely to wear off among the Mirapex patients.
During the first ten weeks of their treatment each was either given Mirapex or levadopa at the maximum tolerated dose.
应用推荐
模块上移
模块下移
不移动